Patents by Inventor Claude Moulin

Claude Moulin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6488027
    Abstract: This invention relates to single dose dry powder inhalers in which medicament is stored in a capsule and is released by piercing the capsule wall with polymer-coated steel pins. Methods of preparation of polymer-coated piercing means and their use in releasing the medicament from the capsule are described.
    Type: Grant
    Filed: September 8, 2000
    Date of Patent: December 3, 2002
    Assignee: Novartis AG
    Inventor: Claude Moulin
  • Patent number: 5010017
    Abstract: The invention relates to a process for the immunological quantitative determination of the T.sub.3 and/or T.sub.4 thyroid hormones.In a process for the immunological quantitative determination of T.sub.4 thyroxine and/or T.sub.3 triiodothyronine present in free form in a sample, T.sub.3 and/or T.sub.4 to be determined are put into competition with thyroglobulin for the sites of anti-T.sub.3 and/or anti-T.sub.4 antibodies present in a limited quantity, whereafter a determination is made of either the quantity of thyroglobulin fixed to the anti-T.sub.3 and/or anti-T.sub.4 antibodies, or the quantity of thyroglobulin not fixed to the anti-T.sub.3 and/or anti-T.sub.4 antibodies.Application to the determination of the total T.sub.3 and/or T.sub.4 of a biological sample.
    Type: Grant
    Filed: August 17, 1990
    Date of Patent: April 23, 1991
    Assignee: Compagnie Oris Industrie S.A.
    Inventors: Bernard Ferrua, Claude Moulin
  • Patent number: 4966838
    Abstract: The invention relates to a process for the immunological quantitative determination of the T.sub.3 and/or T.sub.4 thyroid hormones.In a process for the immunological quantitative determination of T.sub.4 thyroxine and/or T.sub.3 triiodothyronine present in free form in a sample, T.sub.3 and/or T.sub.4 to be determined are put into completion with thyroglobulin for the sites of anti-T.sub.3 and/or anti-T.sub.4 antibodies present in a limited quantity, whereafter a determination is made of either the quantity of thyroglobulin fixed to the anti-T.sub.3 and/or anti-T.sub.4 antibodies, or the quantity of thyroglobulin not fixed to the anti-T.sub.3 and/or anbti-T.sub.4 antibodies.
    Type: Grant
    Filed: May 11, 1987
    Date of Patent: October 30, 1990
    Assignee: Compagnie Oris Industrie S.A.
    Inventors: Bernard Ferrua, Claude Moulin
  • Patent number: 4097415
    Abstract: Improved anodes for solid electrolytic capacitors are produced by introducing in the anode body made of a film forming sintered metal powder one of the following additives : tungsten, molybdenum, vanadium and hafnium, at the most suitable step of the manufacturing process previous to sintering under one of the following forms : pure metal, oxide, sulphide. In a preferred embodiment the additive is introduced in the binder used for pelletizing. In another embodiment the additive is introduced by dipping the presintered anodes in a solution containing said additive.
    Type: Grant
    Filed: March 9, 1976
    Date of Patent: June 27, 1978
    Assignee: Societe Lignes Telegraphiques et Telephoniques
    Inventors: Jean-Claude Moulin, Balint Escher, Dominique Prince
  • Patent number: 3984208
    Abstract: Improved sintered anodes for solid electrolytic capacitors are produced from a mixture of at least two powders the first being of pure film forming metal and the second of a film forming metal with addition of at least one of the elements : nitrogen, tungsten, molybdenum, vanadium and hafnium. The relative concentration of the added element is between 100 and 20,000 ppm. by weight.
    Type: Grant
    Filed: February 13, 1974
    Date of Patent: October 5, 1976
    Assignee: Societe Lignes Telegraphiques et Telephoniques
    Inventors: Jean-Claude Moulin, Balint Escher, Dominique Prince
  • Patent number: D410541
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: June 1, 1999
    Assignee: Novartis AG
    Inventor: Claude Moulin
  • Patent number: D420736
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: February 15, 2000
    Assignee: Novartis AG
    Inventor: Claude Moulin